We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+17.59%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$3.52B
AUM Growth
+$338M
Cap. Flow
-$64.2M
Cap. Flow %
-1.83%
Top 10 Hldgs %
95.27%
Holding
19
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ALKT icon
Alkami Technology
ALKT
+$52.6M
2
OPEN icon
Opendoor
OPEN
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 45.21%
2 Healthcare 37.02%
3 Financials 15.11%
4 Consumer Staples 2.57%
5 Consumer Discretionary 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALHC icon
1
Alignment Healthcare
ALHC
$3.78B
$721M 20.5%
60,993,323
– –
XP icon
2
XP
XP
$8.43B
$531M 15.11%
29,617,733
– –
DLO icon
3
dLocal
DLO
$4.29B
$511M 14.53%
63,906,695
– –
SQSP
4
DELISTED
Squarespace, Inc.
SQSP
$493M 14.01%
10,611,073
– –
ALKT icon
5
Alkami Technology
ALKT
$1.96B
$490M 13.92%
15,520,318
-1,666,667
-10% -$52.6M
CNTA
6
DELISTED
Centessa Pharmaceuticals
CNTA
$155M 4.4%
9,681,818
– –
AKRO
7
DELISTED
Akero Therapeutics
AKRO
$150M 4.27%
5,233,989
– –
PHVS icon
8
Pharvaris
PHVS
$2.28B
$139M 3.97%
7,531,252
– –
EWCZ
9
DELISTED
European Wax Center
EWCZ
$89.2M 2.53%
13,110,492
– –
BLND icon
10
Blend Labs
BLND
$438M
$71.7M 2.04%
19,132,440
– –
RPRX icon
11
Royalty Pharma
RPRX
$26.2B
$42.4M 1.21%
1,500,000
– –
THRD
12
DELISTED
Third Harmonic Bio
THRD
$40.1M 1.14%
2,958,762
– –
IMCR icon
13
Immunocore
IMCR
$1.7B
$39.3M 1.12%
1,261,684
– –
RSKD icon
14
Riskified
RSKD
$719M
$25.2M 0.72%
5,324,998
– –
SLRN
15
DELISTED
ACELYRIN
SLRN
$14.2M 0.41%
2,889,668
– –
LOGC
16
DELISTED
ContextLogic
LOGC
$3.32M 0.09%
609,616
– –
GROV icon
17
Grove Collaborative
GROV
$45.8M
$1.26M 0.04%
936,020
– –
ADAG
18
Adagene
ADAG
$246M
$586K 0.02%
264,000
– –
OPEN icon
19
Opendoor
OPEN
$3.54B
– –
-6,532,236
Closed -$11.6M

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return

General Atlantic's Q3 2024 Portfolio in Review

As of Q3 2024, General Atlantic held 19 positions worth $3.52B, up 11% from $3.18B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

General Atlantic's Q3 2024 filing shows 1 reduced and 1 closed positions. The largest sale was Alkami Technology, an estimated $52.6M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Healthcare and Financials.

  • General Atlantic's biggest Q3 2024 reduction was Alkami Technology, cutting an estimated $52.6M.
  • General Atlantic fully exited Opendoor in Q3 2024, selling an estimated $11.6M.
  • General Atlantic's ten largest holdings make up 95% of its $3.52B portfolio in Q3 2024.
  • General Atlantic opened 0 new positions and closed 1 in Q3 2024.
  • General Atlantic's portfolio value rose 11% quarter-over-quarter to $3.52B.

Based on General Atlantic's 13F filing for Q3 2024, filed 12 Nov 2024.